Excessive alcohol consumption is one of the most important lifestyle factors affecting the disease burden in the Western world. The results of treatment in daily practice are modest at best. The aim of the RESCueH programme is to develop and evaluate methods, which are as practice-near as possible, and therefore can be implemented quickly and easily in everyday clinical practice. It is the first clinical alcohol programme to be transatlantic in scope, with implementation in treatment centers located in Denmark, Germany and the US. The RESCueH programme comprises 5 randomized controlled trials, and the studies can be expected to result in (1) more patients starting treatment in specialized outpatient clinics, (2) a greater number of elderly patients being treated, (3) increased patient motivation for treatment and thus improved adherence, (4) more patients with stable positive outcomes after treatment and (5) fewer patients relapsing into harmful drinking. The aim of this paper is to discuss the rationale for the RESCueH programme, to present the studies and expected results.

Nutt DJ, King LA, Phillips LD; Independent Scientific Committee on Drugs: Drug harms in the UK: a multicriteria decision analysis. Lancet 2010;376:1558-1565.
World Health Organization: Global Health Risks: Mortality and Burden of Disease Atributable to Selected Major Risks. Geneva, World Health Organization, 2009.
Lopez AD, Williams TN, Levin A, Tonelli M, Singh JA, Burney PG, et al: Remembering the forgotten non-communicable diseases. BMC Med 2014;12:200.
Anderson P, Baumberg B: Alcohol in Europe: A Report of the European Commission. London, Institute of Alcohol Studies, 2006.
Laramée P, Kusel J, Leonard S, Aubin HJ, François C, Daeppen JB: The economic burden of alcohol dependence in Europe. Alcohol Alcohol 2013;48:259-269.
Carroll KM, Rounsaville BJ: Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment. Psychiatr Serv 2003;54:333-339.
The National Academies Collection: Reports funded by National Institutes of Health: Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. Washington, The National Academies Press, 2006.
Kohn R, Saxena S, Levav I, Saraceno B: The treatment gap in mental health care. Bull World Health Organ 2004;82:858-866.
Miller WR, Wilbourne PL: Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction 2002;97:265-277.
Berglund M, Thelander S, Jonsson E: Treating Alcohol and Drug Abuse: An Evidence Based Review. Weinheim, Wiley-VCH Verlag Gmbh, 2003.
Pilling S, Yesufu-Udechuku A, Taylor C, Drummond C; Guideline Development Group: Diagnosis, assessment, and management of harmful drinking and alcohol dependence: summary of NICE guidance. BMJ 2011;342:d700.
McLellan AT, Carise D, Kleber HD: Can the national addiction treatment infrastructure support the public's demand for quality care? J Subst Abuse Treat 2003;25:117-121.
Carroll KM, Rounsaville BJ: A vision of the next generation of behavioral therapies research in the addictions. Addiction 2007;102:850-862; discussion 863-869.
Blanco C, Olfson M, Okuda M, Nunes EV, Liu SM, Hasin DS. Generalizability of clinical trials for alcohol dependence to community samples. Drug Alcohol Depend 2008;98:123-128.
Humphreys K, Weingardt KR, Horst D, Joshi AA, Finney JW: Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98. Addiction 2005;100:1249-1257.
Humphreys K, Weisner C: Use of exclusion criteria in selecting research subjects and its effect on the generalizability of alcohol treatment outcome studies. Am J Psychiatry 2000;157:588-594.
Wells KB: Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999;156:5-10.
Patsopoulos NA: A pragmatic view on pragmatic trials. Dialogues Clin Neurosci 2011;13:217-224.
Bosco JL, Silliman RA, Thwin SS, Geiger AM, Buist DS, Prout MN, et al: A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol 2010;63:64-74.
Miller WR, Manuel JK: How large must a treatment effect be before it matters to practitioners? An estimation method and demonstration. Drug Alcohol Rev 2008;27:524-528.
Wei LJ, Lachin JM: Properties of the urn randomization in clinical trials. Control Clin Trials 1988;9:345-364.
Roche AM, Freeman T, Skinner N: From data to evidence, to action: findings from a systematic review of hospital screening studies for high risk alcohol consumption. Drug Alcohol Depend 2006;83:1-14.
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG: AUDIT - The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care, ed 2. Geneva, World Health Organization, 2001.
Schwarz AS, Bilberg R, Bjerregaard L, Nielsen B, Søgaard J, Nielsen AS: Relay model for recruiting alcohol dependent patients in general hospitals - a single-blind pragmatic randomized trial. BMC Health Serv Res 2016;16:132.
Lynge E, Sandegaard JL, Rebolj M: The Danish national patient register. Scand J Public Health 2011;39(7 suppl):30-33.
Andersen K, Bogenschutz MP, Bühringer G, Behrendt S, Bilberg R, Braun B, et al: Outpatient treatment of alcohol use disorders among subjects 60+ years: design of a randomized clinical trial conducted in three countries (elderly study). BMC Psychiatry 2015;15:280.
Søgaard Nielsen A, Ellermann AE: Need to know and wish to know: what individuals find important to know about treatment for alcohol problems in order to be able to decide whether to enter or not. Nord Stud Alcohol Drug 2016;33:123-137.
Mellentin AI, Nielsen B, Nielsen AS, Yu F, Stenager E: A randomized controlled study of exposure therapy as aftercare for alcohol use disorder: study protocol. BMC Psychiatry 2016;16:112.
Sari S, Bilberg R, Jensen K, Nielsen AS, Nielsen B, Roessler KK: Physical exercise as a supplement to outpatient treatment of alcohol use disorders - a randomized controlled trial. BMC Psychol 2013;1:23.
Miller WR, Del Boca FK: Measurement of drinking behavior using the Form 90 family of instruments. J Stud Alcohol Suppl 1994;12:112-118.
Sobell MB, Maisto S, Sobell L, Cooper A, Cooper T, Sanders B: Developing a prototype for evaluating alcohol treatment effectiveness; in Evaluating Alcohol and Drug Abuse Treatment Effectiveness: Recent Advances. 1980, pp 129-150.
Skinner HA, Horn JL: Alcohol Dependence Scale (ADS) User's Guide. Ontario, Addiction Research Foundation, 1984, p 76.
Miller WR, Tonigan JS, Longabaugh R: The Drinker Inventory of Consequences (DrInC): An Instrument for Assessing Adverse Consequences of Alcohol Abuse. Rockville, National Institute on Alcohol Abuse and Alcoholism, 1995.
McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al: The fifth edition of the Addiction Severity Index. Journal of substance abuse treatment. J Subst Abuse Treat 1992;9:199-213.
Babor T H-BJC, Saunders J, Monteiro M: AUDIT - The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. Geneva, World Health Organization, 2001.
Andersen JS, Olivarius Nde F, Krasnik A: The Danish national health service register. Scand J Public Health 2011;39(7 suppl):34-37.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33; quiz 4-57.
Christensen KS, Fink P, Toft T, Frostholm L, Ornbol E, Olesen F: A brief case-finding questionnaire for common mental disorders: the CMDQ. Fam Pract 2005;22:448-557.
Horowitz LM, Alden LE, Wiggins JS: IIP - Inventory of Interpersonal Problems Manual. San Antonio, The Psychological Corporation, 2000.
Derogatis LR, Melisaratos N: The Brief Symptom Inventory: an introductory report. Psychol Med 1983;13:595-605.
Rollnick S, Butler CC, Stott N: Helping smokers make decisions: the enhancement of brief intervention for general medical practice. Patient Educ Couns 1997;31:191-203.
Anton RF: Obsessive-compulsive aspects of craving: Development of the obsessive compulsive drinking scale. Addiction 2000;95 (suppl 2):S211-S217.
Flannery BA, Volpicelli JR, Pettinati HM: Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 1999;23:1289-1295.
Love A, James D, Willner P: A comparison of two alcohol craving questionnaires. Addiction 1998;93:1091-1102.
Wewers ME, Lowe NK: A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 1990;13:227-236.
Skevington SM, Lotfy M, O'Connell KA, Group W: The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. Qual Life Res 2004;13:299-310.
Miller WR: Combined Behavioral Intervention Manual: A Clinical Research Guide for Therapists Treating People with Alcohol Abuse and Dependence. Bethesda, NIAAA, 2004.
Bruce R, Kusumi F, Hosmer D: Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973;85:546-562.
Craig CL, Marshall AL, Sjostrom M, Bauman A, Booth ML, Ainsworth BE, et al: International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395.
DiClemente CC, Carbonari JP, Montgomery RP, Hughes SO: The alcohol abstinence self-efficacy scale. J Stud Alcohol Drugs 1994;55:141-148.
Monti PM: Treating Alcohol Dependence: A Coping Skills Training Guide. Guilford Press, 2002.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.